PAI Partners-backed Ethypharm acquired Pharmy II Laboratory.

The Ethypharm Group has acquired the PHARMY II Laboratory. Financial terms were not disclosed. Pharmy II is a pharmaceutical operating company founded in France in 1982. Well established in France, the Pharmy II laboratory is specialized in the treatment of pain and more particularly mechanical musculo-articular pain. It provides health professionals - rheumatologist, mesotherapist, sports doctor - and their patients, on the French market, a range of solutions intended to be injected locally, by the technique of mesotherapy. Through this acquisition, Ethypharm is expanding its portfolio of six drugs and completing its range of proprietary medicinal products in both injectable and liquid form. "By becoming part of a new "specialized" market, Ethypharm is strengthening its commitment in the field of pain and its support to health players". Bertrand Deluard, Ethypharm Group CEO.